252 related articles for article (PubMed ID: 36529791)
21. Genotype-phenotype associations within the Li-Fraumeni spectrum: a report from the German Registry.
Penkert J; Strüwe FJ; Dutzmann CM; Doergeloh BB; Montellier E; Freycon C; Keymling M; Schlemmer HP; Sänger B; Hoffmann B; Gerasimov T; Blattmann C; Fetscher S; Frühwald M; Hettmer S; Kordes U; Ridola V; Kroiss Benninger S; Mastronuzzi A; Schott S; Nees J; Prokop A; Redlich A; Seidel MG; Zimmermann S; Pajtler KW; Pfister SM; Hainaut P; Kratz CP
J Hematol Oncol; 2022 Aug; 15(1):107. PubMed ID: 35974385
[TBL] [Abstract][Full Text] [Related]
22. Radiotherapy-induced malignancies in breast cancer patients with TP53 pathogenic germline variants (Li-Fraumeni syndrome).
Petry V; Bonadio RC; Cagnacci AQC; Senna LAL; Campos RDNG; Cotti GC; Hoff PM; Fragoso MCBV; Estevez-Diz MDP
Fam Cancer; 2020 Jan; 19(1):47-53. PubMed ID: 31748977
[TBL] [Abstract][Full Text] [Related]
23. Case Report : Li-Fraumeni Syndrome with Central Nervous System Tumors in Two Siblings.
Fang Z; Su Y; Sun H; Ge M; Qi Z; Hao C; Qian S; Ma X
BMC Pediatr; 2021 Dec; 21(1):588. PubMed ID: 34961499
[TBL] [Abstract][Full Text] [Related]
24. Chest wall leiomyosarcoma after breast-conservative therapy for early-stage breast cancer in a young woman with Li-Fraumeni syndrome.
Henry E; Villalobos V; Million L; Jensen KC; West R; Ganjoo K; Lebensohn A; Ford JM; Telli ML
J Natl Compr Canc Netw; 2012 Aug; 10(8):939-42. PubMed ID: 22878818
[TBL] [Abstract][Full Text] [Related]
25. Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study.
Mouchawar J; Korch C; Byers T; Pitts TM; Li E; McCredie MR; Giles GG; Hopper JL; Southey MC
Cancer Res; 2010 Jun; 70(12):4795-800. PubMed ID: 20501846
[TBL] [Abstract][Full Text] [Related]
26. Medical guidelines for Li-Fraumeni syndrome 2019, version 1.1.
Kumamoto T; Yamazaki F; Nakano Y; Tamura C; Tashiro S; Hattori H; Nakagawara A; Tsunematsu Y
Int J Clin Oncol; 2021 Dec; 26(12):2161-2178. PubMed ID: 34633580
[TBL] [Abstract][Full Text] [Related]
27. Li-Fraumeni syndrome.
Ossa CA; Molina G; Cock-Rada AM
Biomedica; 2016 Jun; 36(2):182-7. PubMed ID: 27622479
[TBL] [Abstract][Full Text] [Related]
28. High frequency of germline p53 mutations in childhood adrenocortical cancer.
Wagner J; Portwine C; Rabin K; Leclerc JM; Narod SA; Malkin D
J Natl Cancer Inst; 1994 Nov; 86(22):1707-10. PubMed ID: 7966399
[TBL] [Abstract][Full Text] [Related]
29. Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity.
Penkert J; Schmidt G; Hofmann W; Schubert S; Schieck M; Auber B; Ripperger T; Hackmann K; Sturm M; Prokisch H; Hille-Betz U; Mark D; Illig T; Schlegelberger B; Steinemann D
Breast Cancer Res; 2018 Aug; 20(1):87. PubMed ID: 30086788
[TBL] [Abstract][Full Text] [Related]
30. Early detection of adrenocortical carcinoma in a child with Li-Fraumeni syndrome.
Lin MT; Shieh JJ; Chang JH; Chang SW; Chen TC; Hsu WH
Pediatr Blood Cancer; 2009 Apr; 52(4):541-4. PubMed ID: 19101993
[TBL] [Abstract][Full Text] [Related]
31. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
[TBL] [Abstract][Full Text] [Related]
32. Primary Cutaneous Leiomyosarcoma Arising in a Patient With Li-Fraumeni Syndrome: A Neoplasm With Unusual Histopathologic Features and Loss of Heterozygosity at TP53 Gene.
Sabater-Marco V; Ferrando-Roca F; Morera-Faet A; García-García JA; Bosch SB; López-Guerrero JA
Am J Dermatopathol; 2018 Mar; 40(3):225-227. PubMed ID: 28475508
[No Abstract] [Full Text] [Related]
33. Clinical and molecular characterization of patients fulfilling Chompret criteria for Li-Fraumeni syndrome in Southern Brazil.
Matzenbacher Bittar C; de Araújo Rocha YM; Vieira IA; Rosset C; Andreis TF; Sartor ITS; Artigalás O; Netto CBO; Alemar B; Macedo GS; Ashton-Prolla P
PLoS One; 2021; 16(9):e0251639. PubMed ID: 34529667
[TBL] [Abstract][Full Text] [Related]
34. Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.
Kamihara J; Rana HQ; Garber JE
Hum Mutat; 2014 Jun; 35(6):654-62. PubMed ID: 24706533
[TBL] [Abstract][Full Text] [Related]
35.
da Silva PFF; Goveia RM; Teixeira TB; Gamba BF; de Lima AP; Rogatto SR; Silveira-Lacerda EP
Biomolecules; 2022 Apr; 12(5):. PubMed ID: 35625568
[No Abstract] [Full Text] [Related]
36. First case of endometrial cancer after yolk sac tumor in a patient with Li-Fraumeni syndrome.
Ye QL; Qi Y; Liu JJ; Hu YX; Lv Y; Lin B
BMC Womens Health; 2023 Jun; 23(1):329. PubMed ID: 37344881
[TBL] [Abstract][Full Text] [Related]
37. Hematologic malignancies in Li-Fraumeni syndrome: A case report.
Bundrant B; Gerstein Y; Arun B; DiNardo CD
Am J Med Genet A; 2024 Jul; 194(7):e63573. PubMed ID: 38410872
[TBL] [Abstract][Full Text] [Related]
38. Super-Transactivation TP53 Variant in the Germline of a Family with Li-Fraumeni Syndrome.
Id Said B; Kim H; Tran J; Novokmet A; Malkin D
Hum Mutat; 2016 Sep; 37(9):889-92. PubMed ID: 27297285
[TBL] [Abstract][Full Text] [Related]
39. Gastric cancer in individuals with Li-Fraumeni syndrome.
Masciari S; Dewanwala A; Stoffel EM; Lauwers GY; Zheng H; Achatz MI; Riegert-Johnson D; Foretova L; Silva EM; Digianni L; Verselis SJ; Schneider K; Li FP; Fraumeni J; Garber JE; Syngal S
Genet Med; 2011 Jul; 13(7):651-7. PubMed ID: 21552135
[TBL] [Abstract][Full Text] [Related]
40. Next generation sequencing is informing phenotype: a TP53 example.
O'Shea R; Clarke R; Berkley E; Giffney C; Farrell M; O'Donovan E; Gallagher DJ
Fam Cancer; 2018 Jan; 17(1):123-128. PubMed ID: 28509937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
